Global Neuroprotective Drugs Market By Overview
Neuroprotective drugs help to defend the brain neurons from deterioration and injury. These drugs are used in the treatment of multiple central nervous system (CNS) problems include Alzheimer’s diseases, Retinal disorders, Parkinson’s diseases, traumatic brain injuries, multiple sclerosis, Amyotrophic lateral sclerosis (ALS), Neuropathies, Huntington\'s disease, and other disorders affecting the nervous system. Moreover, neurogenerative diseases and their incidence rate significantly increases with age. Therefore, the demand for neuroprotective drugs would also increase in the coming years, as it helps to increase the average lifespan of a person.
The neuroprotective drugs market is driven by rising prevalence and incidence rate of neurodegenerative diseases, particularly in the aging population and growing requirement for the precise treatment of brain injuries is expected to boost the demand for neuroprotective drugs in the coming years. Furthermore, speedily growing pharmaceutical sector, rising investment in research & development activity results in novel drug discovery as well as product launch are some major driving factor for the neuroprotective drugs market within the forecast period.
However, the high cost of neuroprotective drugs, huge cost involved in research & developmental activity and strict regulatory approvals which increase the failure rates during clinical trials which may hinder the market of neuroprotective drugs over the forecast period.
The neuroprotective drugs market has been segmented on the basis of drug type, application, and region.
The drug type segment includes cholinesterase inhibitors, ion channel modulators, NMDA receptor antagonists, metal ion chelators, and neurotropic factors
On the basis of the application, the neuroprotective drugs market has been segmented into Alzheimer\'s disease, Parkinson\'s disease, and others.
On the basis of region, the neuroprotective drugs market has been segmented into North America, Latin America, Asia Pacific, Europe, Middle East and Africa.
Key players operating in the neuroprotective drugs market includesAllon therapeutics, Inc., Bionure Inc., BHRPharma LLC, Ceregene, Genervon Biopharmaceuticals, Neuren Pharmaceuticals, and NeuroVive Pharmaceutical.
Global Neuroprotective Drugs Market By Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Preview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Application
- Market Snippet, By Region
- Opportunity Map
- Report Description
- Market Dynamics
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Drivers- Restraints Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Market Dynamics
- Market Segmentation, By Drug Type, 2018 – 2028, (US$ Mn)
- Introduction
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
- Y-o-Y Growth Analysis (%), 2019 – 2028
- Segment Trends
- Cholinesterase inhibitors
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Ion channel modulators
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- NMDA receptor antagonists
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Metal Ion Chelators
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Neurotropic factors
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Introduction
- Market Segmentation, By Application, 2018 – 2028, (US$ Mn)
- Introduction
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
- Y-o-Y Growth Analysis (%), 2019 – 2028
- Segment Trends
- Alzheimer\'s disease
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Parkinson\'s disease
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Others
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Introduction
- Global Market, By Region, 2018 – 2028, (US$ Mn)
- Introduction
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
- Y-o-Y Growth Analysis (%), 2019 – 2028
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Drug Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
- Introduction
Ø U.S.
Ø Canada
- Latin America
- Market Size and Forecast (US$ Mn), By Drug Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
Ø Brazil
Ø Mexico
Ø Argentina and Chile
Ø Rest of Latin America
- Europe
- Market Size and Forecast (US$ Mn), By Drug Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
Ø Germany
Ø UK
Ø France
Ø Russia
Ø Italy
Ø Switzerland
Ø Sweden
Ø Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Drug Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
Ø China
Ø India
Ø Australia & New Zealand
Ø Japan
Ø South Korea
Ø Rest of Asia Pacific
- Middle East
- Market Size and Forecast (US$ Mn), By Drug Type, 2018 – 2028
- Size and Forecast, By Applications, 2018 – 2028, (US$ Mn)
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
Ø GCC
Ø Israel
Ø Saudi Arabia
Ø UAE
Ø Rest of Middle East
- Africa
- Market Size and Forecast (US$ Mn), By Drug Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
Ø South Africa
Ø Central Africa
Ø North Africa
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Allon therapeutics, Inc. *
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy Overview
- Bionure Inc.
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy Overview
- BHRPharma LLC
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy Overview
- Ceregene
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy Overview
- Genervon Biopharmaceuticals
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy Overview
- Neuren Pharmaceuticals
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy Overview
- NeuroVive Pharmaceutical
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy Overview
- Analyst Views
- Section
- Research Methodology
- About Us
- Contact
FAQs
The neuroprotective drugs market has been segmented on the basis of drug type, application, and region.
Emerging trends include the development of novel neuroprotective agents, exploration of combination therapies, and the focus on precision medicine approaches for neurodegenerative disorders. Opportunities arise from the increasing prevalence of neurodegenerative diseases, advancements in neuroscience research, and the potential for disease-modifying treatments in various neurological conditions.
Key factors include the rising incidence of neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the need for effective disease-modifying treatments, advancements in understanding the molecular mechanisms of neurodegeneration, and the growing aging population. Additionally, the emphasis on early intervention and the exploration of neuroprotective agents for a range of neurological conditions contribute to market growth.
Regions covered include North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America is expected to dominate the market due to well-established healthcare infrastructure, significant investments in neurodegenerative disease research, and a high prevalence of neurological disorders. However, the Asia-Pacific region is experiencing notable growth, driven by increasing healthcare awareness, a rising aging population, and the expansion of pharmaceutical markets in countries like China and India.
Key players operating in the neuroprotective drugs market includesAllon therapeutics, Inc., Bionure Inc., BHRPharma LLC, Ceregene, Genervon Biopharmaceuticals, Neuren Pharmaceuticals, and NeuroVive Pharmaceutical.